From: Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
HR | 95%CI | p-value | HR | 95%CI | p-value | |
Overall survival | ||||||
Age (< 70) | 0.628 | 0.366–1.077 | 0.091 | |||
Sex (Female) | 0.49 | 0.368–0.651 | < 0.001 | 0.459 | 0.177–1.192 | 0.11 |
pStage (II–IV) | 3.291 | 2.061–5.235 | < 0.001 | 2.344 | 1.4–3.924 | 0.001 |
Smoking history (Yes) | 3.85 | 2.257–6.568 | < 0.001 | 1.346 | 0.533–3.403 | 0.53 |
Histological type (non-adeno) | 3.272 | 2.078–5.153 | < 0.001 | 1.327 | 0.776–2.271 | 0.302 |
Solid TDT (< 400 d) | 3.034 | 1.682–5.473 | < 0.001 | 2.093 | 1.111–3.944 | 0.022 |
Recurrence-free survival | ||||||
Age (< 70) | 1.331 | 0.786–2.254 | 0.287 | |||
Sex (Female) | 0.639 | 0.494–0.827 | 0.001 | 0.318 | 0.128–0.788 | 0.013 |
pStage (II–IV) | 4.067 | 2.537–6.52 | 0.001 | 2.846 | 1.662–4.874 | < 0.001 |
Smoking history (Yes) | 2.161 | 1.325–3.525 | 0.002 | 0.489 | 0.197–1.211 | 0.122 |
Histological type (non-adeno) | 2.897 | 1.811–4.633 | < 0.001 | 1.617 | 0.894–2.922 | 0.112 |
Solid TDT (< 400 d) | 3.152 | 1.673–5.939 | < 0.001 | 2.099 | 1.063–4.144 | 0.033 |